ImmunityBio Inc. (IBRX)
NASDAQ: IBRX
· Real-Time Price · USD
2.54
-0.17 (-6.27%)
At close: Aug 15, 2025, 3:59 PM
2.56
0.59%
After-hours: Aug 15, 2025, 07:58 PM EDT
ImmunityBio Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -367.17M | -409.18M | -413.64M | -587.86M | -597.75M | -601.38M | -583.83M | -458.76M | -474.28M | -430.9M | -417.32M | -400.55M | -377.81M | -372.37M | -349.85M | -326.87M | -304.61M | -267.24M |
Depreciation & Amortization | 16.29M | 16.81M | 17.54M | 17.96M | 18.11M | 18.39M | 18.51M | 19.17M | 19.09M | 18.85M | 18.26M | 16.63M | 15.82M | 15.36M | 14.24M | 12.87M | 12.74M | 12.25M |
Stock-Based Compensation | 35.71M | 35.7M | 34.43M | 38.17M | 45.13M | 46.55M | 49.16M | 45.74M | 41.92M | 41.03M | 40.18M | 41.01M | 44.22M | 51.91M | 57.18M | 47.67M | 34.55M | 17M |
Other Working Capital | -14.6M | -13.89M | -8.47M | -28.21M | -34.64M | -24.76M | 10.45M | 26.3M | 40.82M | 31.89M | 13.7M | 17.49M | -1.92M | -5.57M | -15.39M | -4.37M | 12.66M | 11M |
Other Non-Cash Items | -38K | 15.49M | -18.72M | 160.89M | 194.26M | 202.65M | 173.48M | 31.78M | 26.04M | 7M | 22.3M | 25.61M | 25.56M | 24.9M | 25.43M | 17.69M | 27.35M | 25.59M |
Deferred Income Tax | n/a | n/a | n/a | -24.78M | -38.47M | -28.05M | -28.05M | -3.28M | 10.41M | -4K | -4K | -8K | 6.01M | 6.31M | -2.3M | -2.5M | -10.22M | -10.48M |
Change in Working Capital | -34.35M | -28.98M | -10.84M | -25.75M | -31.28M | -27.59M | 3.98M | 23.14M | 41.42M | 13.96M | -4.1M | -4.3M | -27.5M | -14.99M | -19.11M | -9.24M | 15.54M | 21.79M |
Operating Cash Flow | -349.56M | -370.16M | -391.24M | -421.36M | -410M | -389.43M | -366.76M | -342.21M | -335.41M | -346.89M | -337.51M | -318.42M | -310.54M | -288.88M | -274.42M | -260.38M | -224.66M | -201.09M |
Capital Expenditures | -7.11M | -6.75M | -6.89M | -12.73M | -15.62M | -23.42M | -30.58M | -41.56M | -51.82M | -59.24M | -99.39M | -90.86M | -82.96M | -75.06M | -33.56M | -22.46M | -16.47M | -8.44M |
Cash Acquisitions | -1M | -1M | -1M | -11.2M | -10.2M | -10.2M | -10.15M | 1.06M | -13.71M | -13.71M | -14.77M | -15.77M | 19.5M | 19.5M | 20.5M | 20.51M | 8K | 8K |
Purchase of Investments | -22M | -92.7M | -140.97M | -135.04M | -144.25M | -58.56M | -10.36M | -10.21M | -341K | -388K | -34.31M | -173.29M | -175.69M | -175.74M | -141.75M | -8.86M | -77.2M | -81.56M |
Sales Maturities Of Investments | 92.95M | 127.95M | 136.61M | 128.94M | 59.37M | 24.37M | 10.47M | 158K | 15.01M | 147.76M | 162M | 173.55M | 159.29M | 45.26M | 69.93M | 71.29M | 86.93M | 88.03M |
Other Investing Acitivies | n/a | n/a | -34.36M | -24.16M | -34.11M | -34.19M | 114K | -11.09M | 13.63M | 146.33M | 104.42M | -21.98M | -16.25M | -130.33M | -49.44M | 77.95M | 2.87M | -378K |
Investing Cash Flow | 62.85M | 27.5M | -12.25M | -19.83M | -100.49M | -57.61M | -30.47M | -51.61M | -37.15M | 88.13M | 27.3M | -91.61M | -79.86M | -186.04M | -84.89M | 60.46M | -6.75M | -1.96M |
Debt Repayment | 42K | 21K | n/a | 192.68M | 391.68M | 421.54M | 451.39M | 308.38M | 233.73M | 203.9M | 174.07M | 422.83M | 298.5M | 298.5M | 338.5M | 40M | 103.7M | 103.7M |
Common Stock Repurchased | n/a | n/a | -3.87M | -3.87M | -3.87M | -3.87M | n/a | n/a | -10K | -25K | -397K | -397K | -387K | -372K | -2.62M | -2.64M | -2.64M | -2.68M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -2.37M | 142.92M | 154.37M | 153.68M | 152.54M | 7.33M | -3.15M | -1.81M | -724K | -814K | -881K | -791K | 292K | 98.64M | 97.44M | 97.81M | 96.75M | 85.76M |
Financial Cash Flow | 121.53M | 270.42M | 281.63M | 375.24M | 597.16M | 491.68M | 558.34M | 467.74M | 354.23M | 310.8M | 233.61M | 449.63M | 368.3M | 466.65M | 505.44M | 179.73M | 200.29M | 189.29M |
Net Cash Flow | -69.29M | -72.22M | -121.88M | -66M | 86.61M | 44.56M | 160.82M | 73.81M | -18.39M | 52.24M | -76.31M | 39.78M | -21.91M | -8.29M | 146.19M | -20.16M | -31.2M | -13.97M |
Free Cash Flow | -356.66M | -376.91M | -398.12M | -434.1M | -425.62M | -412.85M | -397.34M | -383.77M | -387.23M | -406.13M | -436.9M | -409.28M | -393.5M | -363.94M | -307.98M | -282.85M | -241.13M | -209.52M |